Biotinylated Anti-Trastuzumab Antibody, Mouse IgG1 (6F2F7-2)

製品番号/仕様
価格
Availability
数量
TRA-BLY5b-25ug
$415.00
In Stock - Delivery in 2-3 business days
TRA-BLY5b-200ug
$1,705.00
In Stock - Delivery in 2-3 business days
TRA-BLY5b
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Chimeric Biotinylated Anti-Trastuzumab Antibody, Mouse IgG1 (6F2F7-2) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to mouse IgG1 constant domains.

Antibody Type

Recombinant Monoclonal

Clone

6F2F7-2

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Conjugate

Biotinylated

Specificity

This product is a specific antibody specifically reacts with Trastuzumab ADA.

Application
Application
Recommended Use / Performance
ELISA
1:600-1:6000
Purification

Protein A purified.

Aggregation

Less than 10%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in Tris (pH 7.5) containing 150 mM NaCl, with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

バックグランド

Trastuzumab, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication. Trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein.